Nathaniel Safren, Ph.D. - Publications

Affiliations: 
2014 Neuroscience University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Neuroscience Biology, Cell Biology, Biochemistry

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Le NT, Chang L, Kovlyagina I, Georgiou P, Safren N, Braunstein KE, Kvarta MD, Van Dyke AM, LeGates TA, Philips T, Morrison BM, Thompson SM, Puche AC, Gould TD, Rothstein JD, et al. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proceedings of the National Academy of Sciences of the United States of America. PMID 27834214 DOI: 10.1073/pnas.1608432113  0.88
2015 Safren N, Chang L, Dziki KM, Monteiro MJ. Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington's disease. Brain Research. 1597: 37-46. PMID 25511991 DOI: 10.1016/j.brainres.2014.12.008  0.88
2014 Safren N, El Ayadi A, Chang L, Terrillion CE, Gould TD, Boehning DF, Monteiro MJ. Ubiquilin-1 overexpression increases the lifespan and delays accumulation of Huntingtin aggregates in the R6/2 mouse model of Huntington's disease. Plos One. 9: e87513. PMID 24475300 DOI: 10.1371/journal.pone.0087513  0.88
2012 Brettschneider J, Van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, Safren N, Monteiro MJ, Toledo JB, Elman L, McCluskey L, Irwin DJ, Grossman M, Molina-Porcel L, Lee VM, et al. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathologica. 123: 825-39. PMID 22426854 DOI: 10.1007/s00401-012-0970-z  0.88
Show low-probability matches.